Caged Garcinia xanthones (CGXs) constitute a family of natural products that are produced by tropical/subtropical trees of the genus Garcinia. CGXs have a unique chemical architecture, defined by the presence of a caged scaffold at the C ring of a xanthone moiety, and exhibit a broad range of biological activities. Here we show that synthetic CGXs exhibit antimalarial activity against Plasmodium falciparum, the causative parasite of human malaria, at the intraerythrocytic stages. Their activity can be substantially improved by attaching a triphenylphosphonium group at the A ring of the caged xanthone. Specifically, CR135 and CR142 were found to be highly effective antimalarial inhibitors, with 50% effective concentrations as low as ∼10 nM. CGXs affect malaria parasites at multiple intraerythrocytic stages, with mature stages (trophozoites and schizonts) being more vulnerable than immature rings. Within hours of CGX treatment, malaria parasites display distinct morphological changes, significant reduction of parasitemia (the percentage of infected red blood cells), and aberrant mitochondrial fragmentation. CGXs do not, however, target the mitochondrial electron transport chain, the target of the drug atovaquone and several preclinical candidates. CGXs are cytotoxic to human HEK293 cells at the low micromolar level, which results in a therapeutic window of around 150-fold for the lead compounds. In summary, we show that CGXs are potent antimalarial compounds with structures distinct from those of previously reported antimalarial inhibitors. Our results highlight the potential to further develop Garcinia natural product derivatives as novel antimalarial agents.
Caged Garcinia Xanthones, a Novel Chemical Scaffold with Potent Antimalarial Activity
Creators
Hangjun Ke - Drexel University
Joanne M Morrisey - Drexel University
Shiwei Qu - University of California, San Diego
Oraphin Chantarasriwong - King Mongkut's University of Technology Thonburi
Michael W Mather - Drexel University
Emmanuel A Theodorakis - University of California, San Diego
Akhil B Vaidya - Drexel University
Publication Details
Antimicrobial agents and chemotherapy, v 61(1)
Publisher
American Society for Microbiology
Number of pages
14
Grant note
AI028398 / HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) (https://doi.org/10.13039/100000060)
CRC-15-380737 / Cancer Research Coordinating Committee
TRG5780085 / Thailand Research Fund (TRF) (https://doi.org/10.13039/501100004396)
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology
Web of Science ID
WOS:000394095800013
Scopus ID
2-s2.0-85009243636
Other Identifier
991019168282504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: